Many metabolic enzymes undergo dynamic rearrangement into large-scale cellular structures in response to specific metabolic cues; a subset form defined filamentous structures in cells [1] [2] [3] [4] [5] [6] [7] . While the enzymes involved are generally well characterized by extensive study of their catalytic mechanisms, monomer structures, and regulation, the filamentous forms remain largely uncharacterized. Where functional data do exist, however, it is clear that metabolic filaments are important for regulating enzyme activity and for maintaining cellular homeostasis [8] [9] [10] [11] [12] .
Many metabolic enzymes undergo dynamic rearrangement into large-scale cellular structures in response to specific metabolic cues; a subset form defined filamentous structures in cells [1] [2] [3] [4] [5] [6] [7] . While the enzymes involved are generally well characterized by extensive study of their catalytic mechanisms, monomer structures, and regulation, the filamentous forms remain largely uncharacterized. Where functional data do exist, however, it is clear that metabolic filaments are important for regulating enzyme activity and for maintaining cellular homeostasis [8] [9] [10] [11] [12] .
Filamentous polymers of CTPS appear to be universally conserved, having been observed in bacteria, yeast, flies, and human cells [1] [2] [3] 13 . CTPS is a focal point for regulation of pyrimidine levels, as it directly converts UTP to CTP. We recently showed that in bacteria the product CTP drives assembly of CTPS into a filament form with lower activity 8 , consistent with the role of CTP as an allosteric inhibitor of CTPS. The polymer is sensitive to substrate-product balance and can rapidly depolymerize into active tetramers in response to changes in substrate concentration. These dynamics buffer the catalytic activity of CTPS to maintain a defined ribonucleotide balance. Importantly, disruption of bacterial CTPS polymerization significantly affects cell growth and metabolism, indicating that polymerization is essential for cellular homeostasis. However, the precise molecular mechanisms of CTP-induced polymerization and inhibition of CTPS have remained unclear. Moreover, while CTPS filaments appear to be universally conserved, it is unknown whether the molecular mechanisms and functional consequences of polymerization are the same across kingdoms.
CTPS directly catalyzes the conversion of UTP to CTP. The enzyme is a homotetramer, with each monomer composed of a glutamine amidotransferase (GAT) domain and a kinase-like ammonia-ligase (AL) domain and joined by an α-helical linker 14 . Ammonia generated in the GAT domain is transferred to the AL domain and then ligated to UTP to form CTP in an ATP-hydrolysis-dependent reaction, with the allosteric regulator GTP playing a role in coupling the reactions. The mechanism of ammonia transfer remains unclear, although a conformational change that alters the relative orientations of the two catalytic domains has been proposed to open an ammonia channel between the active sites 15 . Feedback inhibition occurs through CTP binding at a site that partially overlaps with the UTP substrate-binding site 16 . The catalytic mechanism, domain structures, and the tetrameric quaternary structure of the enzyme are broadly conserved between eukaryotes and bacteria 14, 15, 17, 18 .
Given that the overall structures, catalytic mechanisms, and cellular polymerization of CTPS are conserved from bacteria to humans, it has been widely assumed that the mechanisms and functional consequences of polymerization are conserved for CTPS across species 19 . However, very little is known about the function of CTPS polymerization in eukaryotes beyond the observation that it appears to be part of a cellular stress response and to vary with developmental stage in some organisms 4, 9, 10, 20, 21 . Moreover, recent cell biological studies of CTPS polymerization in eukaryotes came to opposite conclusions about the effects of assembly on enzyme activity 9, 11 .
Here, we use cryo-EM, X-ray crystallography, and kinetic assays to study the allosteric regulation of human and Escherichia coli CTPS A r t i c l e s filaments. We demonstrate that human CTPS filaments assemble in the presence of substrates, have increased catalytic activity, and reveal a novel active conformation of CTPS. Further, we show that both human and E. coli CTPS undergo a conserved conformational cycle controlled by substrate and product binding but have opposite determinants for filament assembly. Given the importance of human CTPS as a target for cancer and immunosuppressive drugs and of bacterial CTPS as a target for antiparasitic treatments, these molecular insights into CTPS structure and allostery may provide novel opportunities to disrupt its function and regulation [22] [23] [24] [25] [26] .
RESULTS

Structure of the ecCTPS filament
To elucidate the mechanism of CTP-induced filament assembly in E. coli CTPS (ecCTPS), we determined the structure of CTP-and ADP-bound ecCTPS filaments at 4.6-Å resolution by cryo-EM (Fig. 1 , Table 1 and Supplementary Fig. 1 ). The ecCTPS filament consists of stacked tetramers that interact through their GAT and linker domains. The tetramer interface is reorganized relative to previous ecCTPS tetramer crystal structures in the apo conformation 14, 16 , bringing the CTPS subunits into closer contact around the bound CTP (Fig. 1c,d) . It was unclear, however, whether this novel ecCTPS conformation was a cause or consequence of filament assembly.
To distinguish between these possibilities, we solved a new ecCTPS-CTP co-crystal structure ( Table 2 ) that reveals a tetramer with quaternary packing nearly identical to that which we observe in the filament (Fig. 1e) . The fact that we observe the same tetramer conformation in the filament and in a crystal without filament-assembly contacts supports the notion that CTP binding allosterically controls ecCTPS assembly by directly inducing a filament-competent conformation of ecCTPS.
The conformational changes between this novel tetramer conformation and the apo state are almost entirely rigid-body motions, with the subunits in each state nearly the same (<0.5 Å C α r.m.s. deviation) but with one exception: helix 218-228 is shifted 3.6 Å closer to the CTP bound on an adjacent monomer so that Phe227 packs against the CTP base. This shift also repositions Asn229 at the base of helix 218-228, creating a new hydrogen-bond network with Arg158 and Glu155 across the tetramer interface, likely stabilizing the filament conformation (Supplementary Fig. 2 ). We previously reported that E155K, a mutation associated with drug resistance through relief of CTPS inhibition 27 , cannot assemble filaments 8 . Our new structure suggests this glutamate-to-lysine mutation interferes with the hydrogen-bond network that occurs across the tetramer interfaces in the inhibited conformation. These changes alter the relative orientations of the polymerization interfaces and position them to allow assembly only in the CTP-bound state (Fig. 1f,g, Supplementary  Videos 1 and 2) .
Allosteric inhibition of ecCTPS in the filament
We next sought to establish the mechanism of polymerizationinduced inhibition of ecCTPS. We considered three possibilities: that substrates are occluded from the active site by assembly contacts, that the filament sterically blocks a conformational change necessary for ammonia transfer, and that the conformation of CTPS in the filament is allosterically inhibitory.
To test these possibilities, we first sought to decouple ecCTPS polymerization from CTP binding by engineering cysteine disulfide crosslinks at filament-assembly interfaces (ecCTPS CC ). Under nonreducing conditions, ecCTPS CC spontaneously polymerizes without nucleotides, and its structure is identical to the wild-type structure minus A r t i c l e s nucleotides ( Fig. 2a-d) . Under reducing conditions, unassembled ecCTPS CC is as active as the wild-type enzyme, but apo-ecCTPS CC filaments preassembled under nonreducing conditions exhibit a fivefold reduction in activity relative to free tetramers, indicating that filament assembly directly inhibits enzymatic activity (Fig. 2e) . When products (CTP and ADP) are soaked into preassembled ecCTPS CC filaments, clear density is observed for the nucleotides in cryo-EM reconstructions, ruling out nucleotide occlusion as a mechanism of inhibition (Fig. 2f) . To test whether filaments impair ammonia transfer between active sites, we measured the activity of ecCTPS CC filaments after adding ammonia directly as a substrate. Under these conditions, ecCTPS CC exhibited the same reduction in activity as the wild type, indicating that inhibition within the filament is not solely the result of an inability to couple the GAT and AL reactions. Finally, we tested whether ecCTPS CC filaments could bind substrates (UTP and ATP) by soaking preassembled filaments with saturating concentrations of nucleotides. Under these conditions, no density is observed for UTP in the active site (Fig. 2f) , suggesting reduced affinity for substrates in the filament conformation. Together, these results indicate that polymerization allosterically regulates ecCTPS activity by stabilizing an intrinsically lower-activity state upon incorporation into filaments, independent of CTP binding.
Assembly and activity of hCTPS polymer
Surprisingly, we found that purified human CTP synthase 1 (hCTPS1) polymerizes in the presence of UTP and ATP substrates but not in the presence of CTP and ADP products, exactly the opposite behavior to that observed with ecCTPS ( Fig. 3a) . hCTPS1 filaments were stable in the presence of UTP, ATP, and GTP, but they disassembled over time upon addition of glutamine, presumably as a result of accumulation of CTP product from the complete synthesis reaction ( Supplementary  Fig. 3a) . Indeed, adding CTP directly to filaments assembled with substrates also resulted in disassembly, while filaments assembled with UTP, the nonhydrolyzable ATP analog AMP-PNP, and GTP were stable following glutamine addition, owing to a lack of CTP synthesis ( Supplementary Fig. 3b,c) . 
A r t i c l e s
To understand how the universally conserved CTPS enzyme could have opposite determinants for filament assembly in bacteria and humans, we solved the cryo-EM structure of hCTPS1 filaments assembled in the presence of substrates UTP and ATP and the allosteric effector GTP at 6.1-Å resolution (Fig. 3b,c, Table 1, Supplementary  Fig. 4) . The UTP-ATP-GTP combination was selected for structure determination as it gave the most robust polymerization of hCTPS1. Like ecCTPS, hCTPS1 is composed of stacked tetramers, but beyond this, the structures differ in their assembly contacts, tetramer interfaces, and protomer conformations. hCTPS1 filament assembly is mediated primarily by an insert in the GAT domain that appeared early in eukaryotic evolution (Fig. 3d, Supplementary Fig. 5a ). This GAT-GAT assembly interaction, which is also observed in the crystal packing of existing structures of isolated hCTPS2 GAT domains (Fig. 3e) , uses a completely different interface from filament assembly in the E. coli enzyme and accounts for the drastic differences in filament architecture between species. There may be additional assembly contacts between C-terminal densities that are predicted to be disordered and are poorly resolved in the cryo-EM structure (Supplementary Fig. 4g ). Like ecCTPS, hCTPS1 assembly is allosterically controlled, but in this case, a novel substrate-bound conformation drives polymerization.
To test the biochemical consequences of polymerization, we mutated a single conserved histidine in the hCTPS1 GAT-domain helical insert (H355A). Unlike the wild-type enzyme, hCTPS1-H355A completely failed to polymerize in the presence of UTP, ATP, and GTP (Fig. 3a, Supplementary Fig. 5b) . A negative-stain reconstruction of hCTPS1-H355A under these conditions confirmed that the overall tetramer structure, which is necessary for CTPS activity, was not affected by the H355A mutation (Supplementary Fig. 5c ). However, the H355A mutation led to a six-fold reduction in hCTPS1 activity (Fig. 3f) , indicating that hCTPS1 activity is enhanced upon subunit assembly into filaments, likely because hCTPS1 is locked in a more active conformation. This assembly of active polymers is in contrast with the suggestion from previous work, including our own description of the ecCTPS filament, that these structures generally function as inactive reservoirs of metabolic capacity 1, 8, 10, 20 . Rather, in some instances, it seems that there may be more complex regulatory schemes in which large-scale polymerization functions to boost enzyme activity.
hCTPS filament structure The hCTPS1 filament structure provides the first view of any CTPS in the substrate-bound active state, which differs from all existing CTPS The active site cryo-EM density from filament structures with no nucleotides present (apo), with products soaked into preformed filaments, or with substrates soaked into preformed filaments. Clear density can be seen for products, while there is no density in the overlapping CTP and UTP sites when substrates are added, suggesting the filament conformation is intrinsically inhibited.
A r t i c l e s structures in both the tetramerization interface and the protomer conformation (Fig. 4) . Density for ATP and UTP substrates is clearly visible in the cryo-EM map, indicating that the hCTPS1 filaments are primed for catalysis upon addition of glutamine (Fig. 4b) . This is consistent with the observation that metabolic filaments assemble in response to glutamine deprivation in cells 21 . Compared with CTPS structures in the inactive state, including the crystal structure of the hCTPS1 AL-domain tetramer, which exhibits analogous packing to that of helices 221-228 and 149-164 in PDB 5TKV, the active hCTPS1 tetramer is extended along the filament axis and compressed perpendicular to the filament axis by approximately 6 Å and 5 Å, respectively (Supplementary Videos 3 and 4), owing to rearrangements of the tetramer interface (Fig. 4c) . Within each hCTPS1 protomer, there is a large conformational change arising from an approximately 10° rotation between the GAT and AL domains relative to all previously reported full-length CTPS structures (Fig. 4d,e) . The rotation is necessary to position the GAT domains for polymerization. In addition, the rotation appears to align two cavities within the GAT and AL domains to form a tunnel. The resolution of our cryo-EM structure is insufficient to clearly describe the nature of this tunnel, but it may function to facilitate ammonia transfer between the two active sites, similar to ammonia tunnels described in other enzymes 28 (Fig. 4f,g ). This would be consistent with earlier predictions that a conformational change is required for ammonia transfer and coupling the GAT and AL reactions 14, 15 .
CTPS conformational states are conserved across kingdoms
We hypothesized that the conformation observed in the hCTPS1 filament is a generally conserved active conformation of the enzyme. However, as there were no previous full-length structures of hCTPS1, we could not rule out the possibility that the unique conformation was specific to the human enzyme. To determine whether ecCTPS adopts the same conformation on substrate binding, we determined the structure of the ecCTPS tetramer bound to UTP and AMP-PNP by cryo-EM at 8 Å (Fig. 5a,b, Table 1 ). The structure has the same overall conformation as the active hCTPS1 filament both at the tetramer interface (Fig. 5c, Supplementary Videos 3 and 4) and in the rotation between the AL and GAT domains (Fig. 5d,e) , confirming that the conformational states of CTPS are conserved from bacteria to humans.
DISCUSSION
The structures of human and bacterial CTPS filaments suggest a model for the allosteric regulation of CTPS polymerization. The conformational equilibrium between apo, substrate-bound, and product-bound states of the CTPS tetramer is universally conserved, while evolutionary divergence at polymerization interfaces has reversed the determinants for filament assembly. The inactive product-bound conformation is stabilized in bacterial filaments, while the active substrate-bound conformation is stabilized in eukaryotic filaments (Fig. 5f) . For both filament types, polymerization may mediate a more cooperative transition between high-and low-activity states, providing more switch-like A r t i c l e s behavior in response to small changes in substrate and product concentrations 8 . What remains unclear is the relative advantage of stabilizing hCTPS in an active conformation in the polymer. One possibility is that stabilizing the polymer under conditions of cellular stress keeps the bulk of hCTPS in a state primed for maximal activity immediately on return to normal growth conditions. Both hCTPS and ecCTPS polymerize through association of their GAT domains. A short helical insertion at this interface both provides the primary assembly interface in hCTPS and prevents hCTPS from assembling with ecCTPS-like contacts (Fig. 4d,e, Supplementary  Fig. 4f) . The approximately ten-residue insertion appeared during early eukaryotic evolution, as only a few early-diverging single-celled lineages lack the insert. This raises the interesting question of how the two different filament forms evolved. One possibility is that CTPS of early eukaryotes formed inhibitory filaments like those of bacteria, and the appearance of the GAT insert switched the filaments to an active state. An alternative is that CTPS polymerization arose independently in bacterial and eukaryotic lineages, so that the appearance of polymerization as being a deeply conserved feature of CTPS actually reflects the independent evolution of CTPS filaments. This may be the more likely scenario, as the appearance of filamentous forms of so many different metabolic enzymes in many different lineages suggests that this is a relatively common evolutionary strategy. Investigating the role of polymerization in earlier-diverging eukaryotes, many of them human pathogens, will be necessary to clarify the evolutionary history of CTPS filaments.
For the many different metabolic enzymes that form filaments, it seems likely that in many cases, like with CTPS, binding of substrates or other ligands allosterically regulates assembly. Moreover, the ability to interconvert between dispersed and polymeric enzyme forms with different intrinsic activities may provide a general mechanism for regulating or localizing metabolic activity under complex cellular conditions. For example, CTPS activity is also regulated by phosphorylation [29] [30] [31] [32] , raising the possibility that post-translational modifications could modulate CTPS activity by influencing filament assembly, shifting the equilibrium between polymers and free tetramers to tune the total level of enzyme activity, independent of substrate and product concentrations. Similarly, binding partners may influence assembly or disassembly of CTPS filaments. This would be analogous to cytoskeletal systems like actin filaments and microtubules in which substrate binding and hydrolysis drive intrinsic polymer dynamics, but multiple factors interact to influence the timing and location of assembly. Indeed, CTPS filaments co-localize with other metabolic and signaling enzymes 4, 9 , suggesting that cellular factors may specifically recognize and interact with metabolic polymers.
Several cell biological studies have shown that eukaryotic CTPS filaments assemble in response to nutrient stress and at particular developmental stages 4,9-11,20,21 . Although some of these studies have A r t i c l e s suggested that eukaryotic CTPS filaments may be composed of catalytically inactive dimers 11, 20 , our work here demonstrates that isolated hCTPS filaments are polymers of active substrate-bound tetramers. Consistent with our results, CTPS in Drosophila germ cells forms filaments at developmental stages with a high demand for CTP, and a constitutively active mutant of hCTPS forms filaments under conditions where the wild-type protein is diffuse throughout the cytoplasm 9 . Experiments in human cells have also shown that metabolic filaments assemble in response to glutamine deprivation and disassemble upon glutamine addition 21 , an effect which we observe here with purified hCTPS1.
Phosphorylation at various sites is known to modulate eukaryotic CTPS activity, leading to changes in cellular concentrations of CTP and phospholipids 29, 31, 32 . Multiple phosphorylation sites are located in the C-terminal tail of hCTPS1 (ref. 30) , which may form assembly contacts in the hCTPS1 filament. It will therefore be interesting to investigate whether phosphorylation has a direct effect on hCTPS1 polymerization, and how enzyme regulation by polymerization is integrated into other regulatory pathways. The CTPS filament structures presented here will provide a mechanistic basis for future investigations of the cellular consequences of polymerization.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. and CTP inhibition as wild type. Protein for crystallization was stored in 10 mM Tris-Cl, 0.5 mM TCEP, pH 8.0 at −80 °C at 10-15 mg/mL. P2 1 2 1 2 crystals isomorphous to the published apo-and CTP/ADP-liganded structures (PDB 1S1M and 2AD5) were grown using vapor diffusion from 7.5 mg/mol ecCTPS-C268A, 0.8-1.2 M ammonium sulfate, 0.1 M Tris-Cl, pH 8.0 as previously described 14 with drops supplemented with 5 mM CTP, 5 mM magnesium sulfate and 10 mM glutamine. For cryoprotection, crystals were briefly rinsed in 1:1 mixture of 50% MPD: mother liquor (25% MPD final), wicked and flash cooled in liquid nitrogen. Reflection data were acquired at Stanford Synchrotron Radiation Lightsource Beamline 1-5 at 100 K at a wavelength of 0.979610 Å and 1° oscillation/image, using a ADSC Quantum 315 detector. 88 frames were processed using DENZO/ Scalepack (HKL2000 package). Phases were derived from the water-free published CTP and ADP complex structure (PDB 2AD5). Maximum-likelihood structure factor refinement was carried out on nonhydrogen atoms using Refmac 5.6 with Babinet scaling with an anisotropic B-factor correction (BSOL fixed at 125.00 and final anisotropic scaling parameters B11 = −1.82, B22 = 2.83, B33 = −1.01, B12 = 0.00, B13 = 0.00, B23 = 0.00). Quaternary changes were accounted for by initial rigid-body refinement for individual monomers and then for three separate domains of each monomer (1-266, 267-287, 288-544) . Cycles of manual model building with Coot 0.6.2 and combined positional and B-factor refinement led to the final model. The distribution of favored, allowed, and outlier Ramachandran angles were 94, 5 and 1%, respectively (51st percentile for structures at this resolution). The data collection and final model statistics are provided in Table 2 .
Sequence comparison. CTPS sequences were obtained from BLAST searches 47 , and multiple sequence alignments of several hundred sequences were performed with MAFFT 48 .
Data availability. Coordinates and structure factors for the CTP-inhibited ecCTPS crystal structure have been deposited in the Protein Data Bank under accession code PDB 5TKV. EM structures and associated atomic models have been deposited in the Electron Microscopy Data Bank and Protein Data Bank with the following accession codes: ecCTPS filament (EMD-8504; PDB 5U3C), hCTPS1 filament (EMD-8474; PDB 5U03), hCTPS1-H355A tetramer
